Non-treated Control Research Articles

EVALUATION OF THE CYSTICIDAL ACTIVITY OF CHLOROCRESOL AGAINST ACANTHAMOEBA POLYPHAGA.

Chlorocresol has antibacterial and antifungal properties, yet its effectiveness in eradicating Acanthamoeba spp. remains unexplored. Acanthamoeba species trophozoites are usually sensitive to biocides, whereas cysts tend to be more resistant. This study aimed to evaluate the cysticidal activity of chlorocresol against Acanthamoeba polyphaga. Chlorocresol concentrations of 0.02, 0.04, and 0.08% were prepared and A. polyphaga cysts were incubated at room temperature (28-37 C) for 1, 24, 48, and 72 hr at each concentration. Cyst viability was evaluated using trypan blue staining and the percentage of nonviable cysts was calculated. For qualification assays, treated cysts were cultured on nonnutrient agar medium coated with Escherichia coli, incubated at 30 C, observed under a stereomicroscope for 30 days, and inoculated into peptone-yeast extract-glucose medium at 30 C for 72 hr. The results revealed that the A. polyphaga cysts were susceptible to 0.02, 0.04, and 0.08% chlorocresol. Chlorocresol made a significant difference in viability (P < 0.001) compared with the nontreated control for the same incubation time. This is the first study to examine the efficacy of chlorocresol against A. polyphaga cysts and it was highly effective. Chlorocresol could thus serve as an alternative chemical disinfectant for the eradication of A. polyphaga cysts as well as a prophylactic against transmission of other pathogenic microorganisms for which Acanthamoeba species can act as a carrier.

C-C Chemokine Receptor 7 Promotes T-Cell Acute Lymphoblastic Leukemia Invasion of the Central Nervous System via β2-Integrins.

C-C Chemokine Receptor 7 (CCR7) mediates T-cell acute lymphoblastic leukemia (T-ALL) invasion of the central nervous system (CNS) mediated by chemotactic migration to C-C chemokine ligand 19 (CCL19). To determine if a CCL19 antagonist, CCL198-83, could inhibit CCR7-induced chemotaxis and signaling via CCL19 but not CCL21, we used transwell migration and Ca2+ mobilization signaling assays. We found that in response to CCL19, human T-ALL cells employ β2 integrins to invade human brain microvascular endothelial cell monolayers. In vivo, using an inducible mouse model of T-ALL, we found that we were able to increase the survival of the mice treated with CCL198-83 when compared to non-treated controls. Overall, our results describe a targetable cell surface receptor, CCR7, which can be inhibited to prevent β2-integrin-mediated T-ALL invasion of the CNS and potentially provides a platform for the pharmacological inhibition of T-ALL cell entry into the CNS.

Assessing Seed Treatments to Control Sudden Death Syndrome Caused by Fusarium virguliforme and Seedling and Root Disease Caused by Rhizoctonia sp. on Mungbean (Vigna radiata)

There is growing interest in producing mungbean ( Vigna radiata L. Wilczek) in the United States, which is driven by increased consumer demand. Strategies are needed for United States farmers to take advantage of this high-value crop and its environmental sustainability. Recommendations for the management of mungbean seedling and root diseases are lacking. Preliminary research in central Iowa mungbean fields from 2019 to 2023 has shown that mungbean is particularly vulnerable to Fusarium virguliforme, the cause of soybean sudden death syndrome (SDS), and Rhizoctonia sp., the cause of damping-off, root decay, premature defoliation, and pod abortion. The purpose of this study was to screen a variety of fungicides as a seed treatment or a soil band application to control root rot in mungbean. We performed three field studies over 2 years using mungbean cultivars Berken and OK2000. Seed treatments Evergol Energy + fluopyram and Evergol Energy + pydiflumetofen showed the highest performance ( P &lt; 0.05), with approximately 30% more healthy roots than nontreated controls. Other treatments exhibited about 20% more healthy roots than the nontreated control. Biotam in-furrow application showed the highest plant population for ‘OK2000’, but we observed no treatment differences in plant stand for ‘Berken’.

Effects of Hybrids, Foliar Treatments, and Infection Conditions on Bacterial Leaf Streak of Sweet Corn.

Bacterial leaf streak (BLS) of corn caused by Xanthomonas vasicola pv. vasculorum was first reported in the United States in 2017. The biology and management of BLS are poorly understood. The objective of this work was to determine the effects of hybrids, foliar treatments, and infection conditions (timing, temperature, and inoculation site) on BLS of sweet corn. Field studies were conducted to determine if hybrid or foliar disease management treatments influenced BLS development and yield. Corn leaves were inoculated in plots with X. vasicola pv. vasculorum, and noninoculated plots were used for comparison. The leaf incidence and severity of BLS differed significantly among sweet corn hybrids, suggesting different levels of susceptibility to BLS. Grain yield was significantly reduced (14.7%) by BLS for one hybrid. The corn growth stage at the time of infection influenced BLS, with incidence and severity significantly greater after inoculation at stage V6 than at V9. Foliar application of Kocide, LifeGard, and Kocide and LifeGard significantly reduced leaf severity compared with nontreated controls in field studies. Kocide significantly reduced leaf incidence, but no treatments significantly increased yield versus controls. In comparisons of inoculation methods in a growth chamber, lesion length on leaves was significantly greater on stalk-inoculated than leaf-inoculated plants. Lesions developed on leaf-inoculated plants only at inoculation sites, whereas lesions developed on stalk-inoculated plants on multiple leaves. In controlled environments, lesion length on leaves was significantly greater at 21°C than at 27 and 32°C. This study expands our understanding of factors that influence the development and management of BLS of sweet corn.

Myristica fragrans Houtt. methanol extract as a promising treatment for Cryptosporidium parvum infection in experimentally immunosuppressed and immunocompetent mice.

Cryptosporidiosis is a major waterborne disease affecting ruminants and humans worldwide. It causes diarrhea and neonatal mortality in buffalo calves, and watery diarrhea and mortality in children and immunodeficient patients. This study aimed to investigate the efficacy of Myristica fragrans methanolic extract in treatment of C. parvum infection in comparison with nitazoxanide (NZX) (a Food and Drug Administration-approved drug control) in immunosuppressed and immunocompetent mice. One hundred laboratory-bred male Swiss albino mice were equally divided into immunocompetent and immunosuppressed groups. Each group was further divided into five subgroups: (1) non-infected and non-treated control, (2) infected and non-treated control (infected with Cryptosporidium parvum oocysts 3 × 103), (3) NZX-treated (100 mg/kg, 200 μL/mouse), (4) M. fragrans Houtt. methanol extract-treated (500 mg/kg), and (5) combination-treated (NZX + M. fragrans extract). Number of oocysts/g of feces, serum immunoglobulin (Ig) G level, and interferon (IFN)-γ, and interleukin (IL)-4 levels were used to evaluate the therapeutic effect. C. parvum oocyst shedding in stool samples was significantly decreased in all treatment groups, with 79.7%, 81.2 %, and 85.5 % reduction in immunocompetent mice treated with NZX, M. fragrans, and their combination, respectively. In immunosuppressed mice, oocyst shedding was reduced by 77.7%, 80.5 %, and 83.7 % upon NZX, M. fragrans, and their combination treatments, respectively. The serum IgG level was lowest in mice treated with a mixture of M. fragrans and NZX, followed by those treated with NZX, and was highest in mice treated with M. fragrans alone. Regarding cytokine levels, all groups treated with M. fragrans had low levels of IFN-γ and IL4 on day 21 post-infection. Collectively, the treatment of cryptosporidiosis with M. fragrans extract was successful in mice, as demonstrated by the measured parameters. M. fragrans reduced C. parvum oocyst shedding and serum IgG, IFN-γ, and IL-4 levels in immunocompetent and immunosuppressed mice.

Sexual and Asexual Propagation of Wild Lime (Zanthoxylum fagara L. Sarg.), a Native Florida Plant with Ornamental and Ecological Value

Abstract A series of four propagation studies were implemented to better understand the seed biology of wild lime (Zanthoxylum fagara L. Sarg. [Rutaceae]) and its adventitious rooting response to auxin treatments. Plant origin (north central vs south Florida ecotypes) did not affect initial seed viability but significantly influenced germination response to seasonal temperatures. Fifty-five days after sowing north central Florida seeds, germination was similar among spring, summer and fall treatments (28.9 to 41.1%), but was reduced by the winter temperature (10.7%). South Florida seeds showed greatest germination under the fall temperature (71.2%), and the least germination under the summer temperature (30.2%). Additional seed treatments including applications of gibberellic acid (GA3) with kinetin nominally improved germination by 1.2 times compared to non-treated seed. Seeds tolerated cryopreservation treatments, including combinations of a plant vitrification solution, liquid nitrogen, phloroglucinol and precooling, suggesting long-term storage capability. As an alternative to seed propagation, cutting propagation was found to be a reliable means of reproducing wild lime with 91.0% rooting success when softwood cuttings were treated with 8,000 mg·kg−1 (0.13 oz·lb−1) indole-butyric acid (IBA), compared to 3,000 mg·kg−1 (0.05 oz·lb−1) IBA (86.3%) or the non-treated control (71.2%). Species used in this study: Wild lime, Zanthoxylum fagara (L. Sarg). Chemicals used in this study: 2,3,5-triphenyl-2H-tetrazolium chloride (TZ); sodium hypochlorite solution (Clorox bleach); gibberellic acid (GA3); kinetin (kinetin), plant vitrification solution 2 (PVS2); liquid nitrogen (LN); phloroglucinol (phloroglucinol); glycerol (glycerol); dimethyl sulfoxide (DMSO); MS media (Murashige and Skoog media), sucrose (sucrose); 15N-5P-15K liquid fertilizer (Peters Excel Cal-Mag Special); indole-3-butyric acid (IBA); 14N-14P-14K slow-release fertilizer (Osmocote).

Reduced WNT4 expression in normal skin fibroblasts leads to ‘Dupuytren-like’ changes in the transcriptome

BackgroundDupuytren's disease (DD) is a fibro-proliferative disorder of unknown aetiology. Previous studies have implicated multiple WNT signalling genes/proteins in Dupuytren pathology, including WNT4. However, it is not yet clear whether WNT signalling dysregulation plays an important role in the initiation of the disease or progression. The aim of this study was to determine if loss of WNT4 expression triggered ‘Dupuytren-like’ changes in the transcriptome of healthy skin fibroblasts. MethodsFibroblasts were isolated from the wrists of healthy adult males and from the wrists and disease cord tissue from males in a family positive for Dupuytren's disease. Normal skin fibroblasts from healthy controls were treated with WNT4 siRNA and scrambled controls. RNASeq was used to analyse the transcriptomes of disease and non-disease fibroblasts from patients with Dupuytren's as well as in siRNA treated and non-treated control fibroblasts. ResultsAnalysis of the transcriptomes from DD patient and normal skin fibroblasts showed significant differences, including in WNT4 expression. Downregulation of WNT4 in normal skin fibroblasts using siRNA led to ‘DD-like’ changes in the transcriptome. ConclusionIn people susceptible to DD WNT4 is downregulated even in non-fibrotic fibroblasts. Knockdown of WNT4 in normal fibroblasts led to changes that made cells ‘DD-like’. This study shows that WNT4 is down regulated in ‘non-disease’ cells, and that downregulating WNT4 in normal skin fibroblasts leads to widespread ‘DD like’ changes in the transcriptome, suggesting WNT4 downregulation is a key driver of DD.

Evaluating tiafenacil and tolpyralate for weed control and basal foliage removal in hops

AbstractIn an effort to find alternatives to paraquat for weed control and basal foliage removal in hops (Hummus lupulus L.), due to regulatory and safety concerns, a study was conducted across Oregon and Washington in 2020 and 2021. The study compared the efficacy of tiafenacil and tolpyralate against a nontreated control and carfentrazone. Applications were made early when hops were 2‐ to 3‐m tall (early), and at over 4 m (late). Tiafenacil showed 55%–85% effectiveness in basal foliage control, slightly higher than carfentrazone, and did not cause crop injury. Tiafenacil at 50 and 100 g a.i. ha−1 controlled Lolium multiflorum (Lam.) Husnot (63%). The mixture of tiafenacil and tolpyralate controlled 80% of L. multiflorum, Cirsium arvense L., and Bassia Scoparia (L.) A.J. Scott. In all cases, control was followed by weed regrowth. No signs of crop injury were observed in any of the studies with tiafenacil. Early applications of tiafenacil reduced yield between 0% and 40% relative to the nontreated control. Late applications of tolpyralate and tiafenacil did not significantly reduce yield. Tolpyralate was as effective as carfentrazone for weed control and basal foliage removal. Early applications of tolpyralate reduced plant height and yield relative to the nontreated control and consistently induced phytochemical injury. Tolpyralate yield reductions ranged from 0% to 84% relative to the nontreated control, depending on the trial. A mixture of tolpyralate and tiafenacil was the most effective treatment tested. We conclude that both tiafenacil and tolpyralate are safe for sucker applications in hops, but careful timing is needed to reduce the risk of injury with tolpyralate. The mixture of tiafenacil and tolpyralate can improve weed control comparable to available options.

Evaluation of Chemical and Biological Products for Control of Crown Gall on Rose.

Crown gall is a soil-borne bacterial disease caused by Agrobacterium tumefaciens, leading to significant economic losses in many plant species. For the assessment of the biological and chemical products on crown gall, each plant's crown region and roots were wounded, and then were dipped into their respective treatments. After the treatments, the plants were inoculated with a suspension of pathogenic A. tumefaciens isolate FBG1034 and maintained in a greenhouse for six months to assess them for gall formation. A quantitative real-time PCR assay was performed to quantify the A. tumefaciens using the chvE gene. Biological products such as the Agrobacterium radiobacter strain K1026, and strains 1 and 2, resulted in the lowest average root gall diameter and significantly reduced the crown gall diameter to stem diameter ratio, and the chemical product copper octanoate reduced the number of crown and root galls as well as the crown and root gall diameter compared to the inoculated, non-treated control. Moreover, both the A. radiobacter strain K1026 and strain 1 treatments resulted in an approximately 85% and 65% reduction in crown and root gall incidence, respectively, in both of the trials compared to the inoculated, non-treated plants. The findings of this study indicate that the use of biological and chemical products could help to suppress crown and root gall disease in rose plants.

Theranostic GPA33-Pretargeted Radioimmunotherapy of Human Colorectal Carcinoma with a Bivalent 177Lu-Labeled Radiohapten.

Radiolabeled small-molecule DOTA-haptens can be combined with antitumor/anti-DOTA bispecific antibodies (BsAbs) for pretargeted radioimmunotherapy (PRIT). For optimized delivery of the theranostic γ- and β-emitting isotope 177Lu with DOTA-based PRIT (DOTA-PRIT), bivalent Gemini (DOTA-Bn-thiourea-PEG4-thiourea-Bn-DOTA, aka (3,6,9,12-tetraoxatetradecane-1,14-diyl)bis(DOTA-benzyl thiourea)) was developed. Methods: Gemini was synthesized by linking 2 S-2-(4-isothiocyanatobenzyl)-DOTA molecules together via a 1,14-diamino-PEG4 linker. [177Lu]Lu-Gemini was prepared with no-carrier-added 177LuCl3 to a molar-specific activity of 123 GBq/μmol and radiochemical purity of more than 99%. The specificity of BsAb-177Lu-Gemini was verified invitro. Subsequently, we evaluated biodistribution and whole-body clearance for [177Lu]Lu-Gemini and, for comparison, our gold-standard monovalent [177Lu]Lu-S-2-(4-aminobenzyl)-DOTA ([177Lu]Lu-DOTA-Bn) in naïve (tumor-free) athymic nude mice. For our proof-of-concept system, a 3-step pretargeting approach was performed with an established DOTA-PRIT regimen (anti-GPA33/anti-DOTA IgG-scFv BsAb, a clearing agent, and [177Lu]Lu-Gemini) in mouse models. Results: Initial invivo studies showed that [177Lu]Lu-Gemini behaved similarly to [177Lu]Lu-DOTA-Bn, with almost identical blood and whole-body clearance kinetics, as well as biodistribution and mouse kidney dosimetry. Pretargeting [177Lu]Lu-Gemini to GPA33-expressing SW1222 human colorectal xenografts was highly effective, leading to absorbed doses of [177Lu]Lu-Gemini for blood, tumor, liver, spleen, and kidneys of 3.99, 455, 6.93, 5.36, and 14.0 cGy/MBq, respectively. Tumor-to-normal tissue absorbed-dose ratios (i.e., therapeutic indices [TIs]) for the blood and kidneys were 114 and 33, respectively. In addition, we demonstrate that the use of bivalent [177Lu]Lu-Gemini in DOTA-PRIT leads to improved TIs and augmented [177Lu]Lu-Gemini tumor uptake and retention in comparison to monovalent [177Lu]Lu-DOTA-Bn. Finally, we established efficacy in SW1222 tumor-bearing mice, demonstrating that a single injection of anti-GPA33 DOTA-PRIT with 44 MBq (1.2 mCi) of [177Lu]Lu-Gemini (estimated tumor-absorbed dose, 200 Gy) induced complete responses in 5 of 5 animals and a histologic cure in 2 of 5 (40%) animals. Moreover, a significant increase in survival compared with nontreated controls was noted (maximum tolerated dose not reached). Conclusion: We have developed a bivalent DOTA-radiohapten, [177Lu]Lu-Gemini, that showed improved radiopharmacology for DOTA-PRIT application. The use of bivalent [177Lu]Lu-Gemini in DOTA-PRIT, as opposed to monovalent [177Lu]Lu-DOTA-Bn, allows curative treatments with considerably less administered 177Lu activity while still achieving high TIs for both the blood (>100) and the kidneys (>30).

Mitigating aging and doxorubicin induced bone loss in mature mice via mechanobiology based treatments

Aging leads to a reduced anabolic response to mechanical stimuli and a loss of bone mass and structural integrity. Chemotherapy agents such as doxorubicin exacerbate the degeneration of aging skeleton and further subject older cancer patients to a higher fracture risk. To alleviate this clinical problem, we proposed and tested a novel mechanobiology-based therapy. Building upon prior findings that i) Yoda1, the Piezo1 agonist, promoted bone growth in young adult mice and suppressed bone resorption markers in aged mice, and ii) moderate tibial loading protected bone from breast cancer-induced osteolysis, we hypothesized that combined Yoda1 and moderate loading would improve the structural integrity of adult and aged skeletons in vivo and protect bones from deterioration after chemotherapy. We first examined the effects of 4-week Yoda1 (dose 5 mg/kg, 5 times/week) and moderate tibial loading (4.5 N peak load, 4 Hz, 300 cycles for 5 days/week), individually and combined, on mature mice (∼50 weeks of age). Combined Yoda1 and loading was found to mitigate age-associated cortical and trabecular bone loss better than individual interventions. As expected, the non-treated controls experienced an average drop of cortical polar moment of inertia (Ct.pMOI) by −4.3 % over four weeks and the bone deterioration occurred in the majority (64 %) of the samples. Relative to no treatment, loading alone, Yoda1 alone, and combined Yoda1 and loading increased Ct.pMOI by +7.3 %, +9.5 %, +12.0 % and increased the % of samples with positive Ct.pMOI changes by +32 %, +26 %, and +43 %, respectively, suggesting an additive protection of aging-related bone loss for the combined therapy. We further tested if the treatment efficacy was preserved in mature mice following two weeks (six injections) of doxorubicin at the dose of 2.5 or 5 mg/kg. As expected, doxorubicin increased osteocyte apoptosis, altered bone remodeling, and impaired bone structure. However, the effects induced by DOX were too severe to be rescued by Yoda1 and loading, alone or combined, although loading and Yoda1 individually, or combined, increased the number of mice showing positive responsiveness by 0 %, +15 %, and +29 % relative to no intervention after doxorubicin exposure. Overall, this study supported the potentials and challenges of the Yoda1-based strategy in mitigating the detrimental skeletal effects caused by aging and doxorubicin.

Unveiling the Role of Metal Ion Concentration versus Immune Sensitization in Orthodontic Patients-A Long-Term Prospective Evaluation.

Background: This longitudinal prospective study aimed to assess orthodontic patients' immune system response to metal ion release in saliva. Methods: Thirty adult patients (18-35 years) were equally divided into three groups: groups at the end (G1) and beginning (G2) of multibracket appliances (MBA) treatment and a non-treated control group (G3). Participants were evaluated at four timepoints within 21 days, with saliva samples being analyzed for metal ion concentrations and blood for the lymphocyte transformation test (LTT). Results: There were no significant differences between groups or timepoints for saliva. LTT analyses revealed hypersensitivity in one-third of all patients and 50% of G2 for nickel, with three developing sensitizations after MBA insertion. All nickel-sensitized patients exhibited varying elevated saliva nickel concentrations. The most nickel-sensitized patients had low ion saliva loads. In borderline nickel-sensitization cases, saliva ion concentrations were up to 20 times higher than the reference. Hypersensitivity to palladium, gold, and mercury was also observed. Conclusions: These findings indicate that increased MBA ion release was not inherently linked to the immune response (Type-IV sensitization), as reactions occurred even with ion levels below thresholds. This underlines the need for a comprehensive evaluation of the immune response to metal ion release in orthodontic patients.

Protective effect of sevoflurane on myocardial ischemia-reperfusion injury: a systematic review and meta-analysis.

Myocardial ischemia-reperfusion (I/R) injury significantly impacts recovery in both cardiac and non-cardiac surgeries, potentially leading to severe cardiac dysfunction. Sevoflurane, a volatile anesthetic, is reputed for its protective effects against myocardial I/R injury, although evidence remains inconclusive. This systematic review and meta-analysis aim to clarify the cardioprotective efficacy of sevoflurane. The systematic search of databases including Medline, Embase, Scopus, and Web of Science, was supplemented with a manual search to retrieve studies using rat or mouse models of myocardial I/R injury, comparing sevoflurane pretreatment (≥ 24 hours before I/R), preconditioning (within 24 hours before I/R), or post-conditioning (after I/R) against non-treated controls. The outcomes were cardiac function, myocardial infarct size, apoptosis, inflammation, oxidative stress, and cardiac biomarkers. Using the random effects model, standardized mean differences (SMD) were pooled to perform meta-analyses. Fifty-one studies, encompassing 8189 subjects, were included in the meta-analysis. Pretreatment with Sevoflurane significantly reduced infarct size. Sevoflurane preconditioning exhibited positive effects on left ventricular parameters and ejection fraction, and reduced infarct size, apoptosis, and oxidative stress. Post-conditioning with Sevoflurane demonstrated improvements in cardiac function, including enhanced left ventricular parameters and reduced infarct size, apoptosis, inflammation, oxidative stress, and cardiac biomarkers. Sevoflurane demonstrates a significant protective effect against myocardial I/R injury in animal models. These findings support the potential clinical utility of sevoflurane as an anesthetic choice in preventing and managing myocardial I/R injury during surgeries.

Subsurface Drainage and Nitrogen Fertilizer Management Affect Fertilizer Fate in Claypan Soils

Sustainable nitrogen (N) fertilizer management practices in the Midwest U.S. strive to optimize crop production while minimizing N gas emission losses and nitrate-N (NO3-N) losses in subsurface drainage water. A replicated site in upstate Missouri from 2018 to 2020 investigated the influence of different N fertilizer management practices on nutrient concentrations in drainage water, nitrous oxide (N2O) emissions, and ammonia (NH3) volatilization losses in a corn (Zea mays, 2018, 2020)–soybean (Glyince max, 2019) rotation. Four N treatments applied to corn included fall anhydrous ammonia with nitrapyrin (fall AA + NI), spring anhydrous ammonia (spring AA), top dressed SuperU and ESN as a 25:75% granular blend (TD urea), and non-treated control (NTC). All treatments were applied to subsurface-drained (SD) and non-drained (ND) replicated plots, except TD urea, which was only applied with SD. Across the years, NO3-N concentration in subsurface drainage water was similar for fall AA + NI and spring AA treatments. The NO3-N concentration in subsurface drainage water was statistically (p &lt; 0.0001) lower with TD urea (9.1 mg L−1) and NTC (8.9 mg L−1) compared to fall AA + NI (14.6 mg L−1) and spring AA (13.8 mg L−1) in corn growing years. During corn years (2018 and 2020), cumulative N2O emissions were significantly (p &lt; 0.05) higher with spring AA compared to other fertilizer treatments with SD and ND. Reduced corn growth and plant N uptake in 2018 caused greater N2O loss with TD urea and spring AA compared to the NTC and fall AA + NI in 2019. Cumulative NH3 volatilization was ranked as TD urea &gt; spring AA &gt; fall AA + NI. Due to seasonal variability in soil moisture and temperature, gas losses were higher in 2018 compared to 2020. There were no environmental benefits to applying AA in the spring compared to AA + NI in the fall on claypan soils. Fall AA with a nitrification inhibitor is a viable alternative to spring AA, which maintains flexible N application timings for farmers.

CO2 Laser-labeling on Fresh Produce: Evaluating Postharvest Quality, Microbial Safety, and Economic Analysis

Fresh produce is traditionally labeled with plastic price lookup (PLU) stickers that are attached to the produce surface using edible glue. However, both the stickers and glue are environmental contaminants, and the stickers can still easily detach from the produce surface during handling and disrupt traceability. An alternative method of labeling, the CO2 laser-labeling technology (LLT), has been gaining attention in recent years. However, engraving Quick Response (QR) code using LLT is unique, and the performance of this technology varies from produce item to produce item, and information on its effects on postharvest quality, microbial safety, and economic feasibility has not been reported. The objectives of this study were to investigate the effect of laser-labeling technology on (1) postharvest quality, (2) microbial safety, and (3) economic analysis of this technology. Three horticultural crops, ‘Red Delicious’ apple (Malus pumila), green bell pepper (Capsicum annuum), and cucumber (Cucumis sativus) were procured from a local grocery store. Each produce was engraved with a Quick Response (QR) code or 6-digit alphanumerical (text) code using the commercially available Trotec Speedy 300 CO2 laser engraver, followed by the application of edible wax. Fresh weight loss for laser-printed produce was higher compared to controls, but no difference in visual quality ratings was observed. The laser-labeled produce was assessed for microbial contamination by artificially inoculating rifampicin-resistant Escherichia coli (E. coli) log10 6 CFU/mL to the labeled fruit. The results showed that the population of rifampicin-resistant E. coli was statistically higher in all three products labeled with text code compared to the nontreated controls. The QR-coded treatments were similar to the controls. The wax application did not affect the microbial attachment on the laser-labeled produce. The CO2 laser labeling technology has the potential for industrial application.

Visfatin (NAMPT) affects global gene expression in porcine anterior pituitary cells during the mid-luteal phase of the oestrous cycle

BackgroundThe pituitary belongs to the most important endocrine glands involved in regulating reproductive functions. The proper functioning of this gland ensures the undisturbed course of the oestrous cycle and affects the female’s reproductive potential. It is believed that visfatin, a hormone belonging to the adipokine family, may regulate reproductive functions in response to the female’s metabolic state. Herein we verified the hypothesis that suggests a modulatory effect of visfatin on the anterior pituitary transcriptome during the mid-luteal phase of the oestrous cycle.ResultsRNA-seq analysis of the porcine anterior pituitary cells revealed changes in the expression of 202 genes (95 up-regulated and 107 down-regulated in the presence of visfatin, when compared to the non-treated controls), assigned to 318 gene ontology terms. We revealed changes in the frequency of alternative splicing events (235 cases), as well as long noncoding RNA expression (79 cases) in the presence of the adipokine. The identified genes were associated, among others, with reproductive system development, epithelial cell proliferation, positive regulation of cell development, gland morphogenesis and cell chemotaxis.ConclusionsThe obtained results indicate a modulatory influence of visfatin on the regulation of the porcine transcriptome and, in consequence, pituitary physiology during the mid-luteal phase of the oestrous cycle.

Cold Atmospheric Plasma (CAP) Treatment of In Vitro Cultivated Plum Plantlets—A Possible Way to Improve Growth and Inactivate Plum Pox Virus (PPV)

Plasma technology, relatively new in the fields of biomedicine, agriculture, and ecology, is the subject of intensive research as a prospective means of decontamination of various microorganisms (bacteria, viruses, and fungi). The objectives of the present study were to follow the effect of cold atmospheric plasma (CAP) treatment on in vitro grown plum plants (Prunus domestica L. ‘Kyustendilska sinya’ cv.) and the possibility of eradicating or inactivating plum pox virus (PPV) causing Sharka disease by CAP. The source tree is naturally co-infected by PPV (both M and D strains). In the experiments, two different plasma sources were used. First, a surface-wave-sustained Argon plasma torch and second, an underwater diaphragm discharge. For the treatments, nodal segments (10 mm in length) from in vitro cultured plum plants with or without one leaf were prepared. Apical shoots from treated plants (PPV-positive and negative clones as well non-treated controls) were cultivated in vitro for four passages. Then they were rooted and acclimatized to ex vitro conditions, and their virus status was observed periodically for more than 3 years after treatment for the appearance of Sharka symptoms. All plants, acclimatized to ex vitro conditions, were tested for PPV by immune capture–reverse transcription–polymerase chain reaction (IC-RT-PCR). As a first step in understanding the plasma treatment of living plants, a plasma treatment variant causing no damage must be established; this has been done in our previous works. Treatment of plants by plasma with parameters that have been carefully selected leads to better development than the non-treated plants. In the treated in vitro plants, no significant differences were found in the number and length of shoots compared to the control plantlets. In ex vitro acclimated plants, greater stem length was reported, but no differences in leaf number were observed. No significant differences in growth were recorded between the control and plants that were treated twice or three times. At this stage, 3 years after ex vitro cultivation in a greenhouse, Sharka symptoms were not registered on treated in vitro negative PPV plants, and the virus was not detected by IC-RT-PCR. Very mild symptoms were showing in CAP-treated PPV-positive plants. Development of typical Sharka symptoms on non-treated controls were observed.

Biomechanical effects of hemin and sildenafil treatments on the aortic wall of chronic-hypoxic lambs.

Introduction: Gestation under chronic hypoxia causes pulmonary hypertension, cardiovascular remodeling, and increased aortic stiffness in the offspring. To mitigate the neonatal cardiovascular risk, pharmacological treatments (such as hemin and sildenafil) have been proposed to improve pulmonary vasodilation. However, little is known about the effects of these treatments on the aorta. Therefore, we studied the effect of hemin and sildenafil treatments in the aorta of lambs gestated and raised at highlands, thereby subjected to chronic hypoxia. Methods: Several biomechanical tests were conducted in the descending thoracic aorta (DTA) and the distal abdominal aorta (DAA), assessing 3 groups of study of hypoxic animals: non-treated (Control) and treated either with hemin or sildenafil. Based on them, the stiffness level has been quantified in both zones, along with the physiological strain in the unloaded aortic duct. Furthermore, a morphological study by histology was conducted in the DTA. Results: Biomechanical results indicate that treatments trigger an increment of axial pre-stress and circumferential residual stress levels in DTA and DAA of lambs exposed to high-altitude chronic hypoxia, which reveals a vasodilatation improvement along with an anti-hypertensive response under this characteristic environmental condition. In addition, histological findings do not reveal significant differences in either structure or microstructural content. Discussion: The biomechanics approach emerges as a valuable study perspective, providing insights to explain the physiological mechanisms of vascular function. According to established results, alterations in the function of the aortic wall may not necessarily be explained by morphostructural changes, but rather by the characteristic mechanical state of the microstructural components that are part of the studied tissue. In this sense, the reported biomechanical changes are beneficial in mitigating the adverse effects of hypobaric hypoxia exposure during gestation and early postnatal life.

Evaluation of fungicides to manage rice false smut (Ustilaginoidea virens) in the hills of Nepal

Rice False Smut (RFS) caused by Ustilaginoidea virens is a major emerging disease of rice due to expanded area of hybrid rice cultivars, increasing use of nitrogenous fertilizers and change in climate. Due to the increasing incidences of this disease across the globe, there is a pressing need to develop techniques for false smut management. The application of fungicides with high efficiency, low toxicity, and low residue is currently the best option to control RFS. Therefore, current research was conducted to determine the effectiveness of fungicides to manage RFS. The experiments were conducted in a completely randomized block design with three replications of seven treatments at RFS-prone subtropical hills of Nepal in the main rice growing season, during 2020 and 2021. The fungicides include trifloxystrobin 25 % + tebuconazole 50 %, chlorothalonil 75 %, carbendazim 12 % + mancozeb 63 %, propiconazole 25 %, azoxystrobin 50 %, carbendazim 50 % and untreated control. Fungicides were applied as two foliar sprays, one at booting and the other at flowering. Fungicide spray significantly increased number of tillers per plant (P ≤ 0.01) and reduced the number of false smut-infected tillers per plant (P ≤ 0.05), false smut severity (P ≤ 0.05), and incidence (P ≤ 0.05). False smut incidence percentages were significantly reduced by all the fungicides except mancozeb + carbendazim compared to the non-treated control. The reduction in RFS incidence was 70 % in propiconazole, 71 % in trifloxystrobin + tebuconazole sprayed plots compared to the non-treated control plots. Thus, the application of suitable fungicide at the appropriate stage would give the satisfactory suppression of RFS in a farmers' field in Nepal.

Rice response to fluridone following topsoil removal on a precision‐leveled field

AbstractFurrow‐irrigated rice (Oryza sativa L.) production requires additional management options without the cultural strategy of a flood. In 2023, fluridone (Brake) was registered for use in rice production. Precision‐leveling land is an important aspect of maintaining an effective irrigation flow path; however, the removal of topsoil can severely impact crop response from residual herbicides. The objective of this study was to evaluate the impact of fluridone on rice response when applied to a precision‐leveled field following topsoil removal. An on‐farm field study was conducted in 2023 near Osceola, AR, with a Sharkey‐Steele clay complex soil texture. The study consisted of six herbicide treatments applied at the rice three‐leaf stage. These treatments included clomazone, quinclorac, and fluridone at three rates (0.5×, 1×, and 2× of a label rate) and a nontreated control. Across evaluation times, maximum visual rice injury was greater than 25% and 65% for the fluridone 1× and 2× treatments, respectively. Rice canopy coverage was reduced in the fluridone 1× and 2× treatments compared to all other treatments from 6 to 10 weeks after application (WAA). Rice heading in the fluridone 2x treatment was delayed by more than 60 and 30 percentage points at 11 and 12 WAA, respectively, compared to all other treatments. Rough rice yield in the fluridone 2× treatment was reduced by 21% compared to all other treatments. Overall, fluridone 1× and 2× rates caused substantial rice injury and would not be recommended on a precision‐leveled field.